Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Viruses
|
March 28, 2026
Wastewater Surveillance for SARS-CoV-2 in Rural Kentucky, 2021-2023
James W Keck, Reuben Adatorwovor, Ann Noble, et al.
Trials
|
September 1, 2016
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization
Alexandra R Brown, Byron J Gajewski, Lauren S Aaronson, et al.
Emerging Infectious Diseases
|
February 26, 2024
Wastewater Surveillance for Identifying SARS-CoV-2 Infections in Long-Term Care Facilities, Kentucky, USA, 2021-2022
James W Keck, Reuben Adatorwovor, Matthew Liversedge, et al.
Journal of Proteome Research
|
June 12, 2013
Characterization of molecules binding to the 70K N-terminal region of fibronectin by IFAST purification coupled with mass spectrometry
S Farshid Moussavi-Harami, Douglas S Annis, Wenjiang Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer
Thomas B Julian, Peter Blumencranz, Kenneth Deck, et al.
Plos One
|
December 3, 2015
Using Exclusion-Based Sample Preparation (ESP) to Reduce Viral Load Assay Cost
Scott M Berry, Hannah M Pezzi, Eram D Williams, et al.
JAMA Oncology
|
February 26, 2016
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis
Kristine R Broglio, Melanie Quintana, Margaret Foster, et al.
Drugs
|
October 26, 2022
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Maha Assi, Christine Lee, et al.
Drugs
|
November 7, 2022
Correction to: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Maha Assi, Christine Lee, et al.
Lab on a Chip
|
October 19, 2018
Versatile exclusion-based sample preparation platform for integrated rare cell isolation and analyte extraction
Hannah M Pezzi, David J Guckenberger, Jennifer L Schehr, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Viruses
|
March 28, 2026
Wastewater Surveillance for SARS-CoV-2 in Rural Kentucky, 2021-2023
James W Keck, Reuben Adatorwovor, Ann Noble, et al.
Trials
|
September 1, 2016
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization
Alexandra R Brown, Byron J Gajewski, Lauren S Aaronson, et al.
Emerging Infectious Diseases
|
February 26, 2024
Wastewater Surveillance for Identifying SARS-CoV-2 Infections in Long-Term Care Facilities, Kentucky, USA, 2021-2022
James W Keck, Reuben Adatorwovor, Matthew Liversedge, et al.
Journal of Proteome Research
|
June 12, 2013
Characterization of molecules binding to the 70K N-terminal region of fibronectin by IFAST purification coupled with mass spectrometry
S Farshid Moussavi-Harami, Douglas S Annis, Wenjiang Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer
Thomas B Julian, Peter Blumencranz, Kenneth Deck, et al.
Plos One
|
December 3, 2015
Using Exclusion-Based Sample Preparation (ESP) to Reduce Viral Load Assay Cost
Scott M Berry, Hannah M Pezzi, Eram D Williams, et al.
JAMA Oncology
|
February 26, 2016
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis
Kristine R Broglio, Melanie Quintana, Margaret Foster, et al.
Drugs
|
October 26, 2022
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Maha Assi, Christine Lee, et al.
Drugs
|
November 7, 2022
Correction to: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Maha Assi, Christine Lee, et al.
Lab on a Chip
|
October 19, 2018
Versatile exclusion-based sample preparation platform for integrated rare cell isolation and analyte extraction
Hannah M Pezzi, David J Guckenberger, Jennifer L Schehr, et al.
Page
of 12